Publications by authors named "G D Kitas"

Article Synopsis
  • The cardiovascular health of patients with rheumatoid arthritis (RA) is a critical issue, as they face more than double the risk of heart disease due to factors like chronic inflammation and lifestyle choices.
  • Current calculators for assessing cardiovascular risk in RA patients aren't significantly better than those used for the general population, making accurate diagnosis a challenge.
  • There is a need for a collaborative approach among various health care providers to improve cardiovascular risk management for RA patients, and this review aims to outline existing assessment and treatment options in this area.
View Article and Find Full Text PDF

Background: The cardiovascular disease (CVD) risk is elevated by 1.5 times among South Asians with rheumatological conditions like rheumatoid arthritis (RA) in the UK. However, there is a dearth of culturally sensitive educational interventions tailored to this population.

View Article and Find Full Text PDF

Patients with systemic autoimmunity due to autoimmune rheumatic diseases (ARDs) or sarcoidosis frequently present with systemic manifestations including cardiac involvement. Cardiac rhythm disturbances and specifically ventricular arrhythmias (VAs) may affect the prognosis of these patients. Cardiovascular magnetic resonance imaging (CMR) is a non-invasive imaging modality that can provide valuable diagnostic and prognostic information in patients with ARDs or systemic autoimmunity in general.

View Article and Find Full Text PDF

Objectives: Chronic inflammation promotes cardiovascular risk in rheumatoid arthritis (RA). Biological disease-modifying antirheumatic drugs (bDMARDs) improve disease activity and cardiovascular disease outcomes. We explored whether bDMARDs influence the impact of disease activity and inflammatory markers on long-term cardiovascular risk in RA.

View Article and Find Full Text PDF

Background: The field of precision medicine endeavors to transform the healthcare industry by advancing individualised strategies for diagnosis, treatment modalities, and predictive assessments. This is achieved by utilizing extensive multidimensional biological datasets encompassing diverse components, such as an individual's genetic makeup, functional attributes, and environmental influences. Artificial intelligence (AI) systems, namely machine learning (ML) and deep learning (DL), have exhibited remarkable efficacy in predicting the potential occurrence of specific cancers and cardiovascular diseases (CVD).

View Article and Find Full Text PDF